CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020
Cash Flows From Operating Activities:
Net earnings (loss)	$ 105,913	$ (83,475)
Adjustments to reconcile net earnings (loss) to cash flows from operating activities:
Depreciation	28,592	33,389
Amortization of intangible assets	660	834
Impairment of goodwill and intangible assets		60,452
Equity compensation expense	5,854	5,626
Gain on sale of investment in unconsolidated entity	(11,586)
Amortization of deferred financing costs	258	258
Change in fair value of contingent consideration	786
Deferred income taxes	3,115	(8,024)
Changes in operating assets and liabilities, net of acquisitions and dispositions:
Receivables, net	(14,341)	19,662
Inventories, net	32,544	3,716
Income tax receivable	(109)	75
Prepaid expenses and other current assets	(3,238)	4,275
Current liabilities	10,361	(747)
Other balance sheet changes	(1,724)	(13,364)
Cash provided by operating activities	157,085	22,677
Cash Flows From Investing Activities:
Purchases of property and equipment	(25,132)	(21,916)
Purchases of short-term investments	(150,000)
Proceeds from sale of investment in unconsolidated entity	14,586
Other investing activities	(2,000)	(3,000)
Cash used in investing activities	(162,546)	(24,916)
Cash Flows From Financing Activities:
Repayment of revolving credit arrangements		(222,896)
Proceeds from revolving credit arrangements		257,698
Repurchase of common stock		(18,053)
Proceeds from issuance of common stock	1,044	1,097
Repurchase of equity awards for employee tax withholding liabilities	(2,983)	(1,870)
Cash dividends paid	(20,447)	(12,706)
Other financing activities	(749)	(459)
Cash (used in) provided by financing activities	(23,135)	2,811
Net change in cash and cash equivalents	(28,596)	572
Effect of foreign currency translation on cash and cash equivalents	559	39
Cash and cash equivalents at the beginning of year	66,013	52,460
Cash and cash equivalents at the end of period	$ 37,976	$ 53,071